Acelyrin News

Acelyrin Insider Sellers Miss The Bus As Stock Jumps 13%

Although Acelyrin, Inc. (NASDAQ:SLRN) shareholders have enjoyed a great week with the stock up 13%, insiders who sold stock over the past year haven't fared as well. The return on their investment wo

Simply Wall StJun 12 08:09 ET

Express News | ACELYRIN, Inc. Announces Positive 16-Week Data From Its Global Phase 2B/3 Trial of Izokibep in Psoriatic Arthritis to Be Shared During Late-Breaking Oral Presentation at Eular 2024

ReutersJun 5 07:00 ET

Piper Sandler Maintains Acelyrin(SLRN.US) With Buy Rating, Maintains Target Price $68

Piper Sandler analyst Yasmeen Rahimi maintains $Acelyrin(SLRN.US)$ with a buy rating, and maintains the target price at $68.According to TipRanks data, the analyst has a success rate of 34.3% and a to

moomoo NewsMay 24 07:33 ET

Analysts Offer Insights on Healthcare Companies: ACELYRIN, INC. (SLRN), Arrowhead Pharmaceuticals (ARWR) and NovoCure (NVCR)

TipRanksMay 24 06:50 ET

H.C. Wainwright Maintains Acelyrin(SLRN.US) With Buy Rating, Raises Target Price to $18

H.C. Wainwright analyst Emily Bodnar maintains $Acelyrin(SLRN.US)$ with a buy rating, and adjusts the target price from $16 to $18.According to TipRanks data, the analyst has a success rate of 37.3% a

moomoo NewsMay 23 06:32 ET

Analysts Offer Insights on Healthcare Companies: Poseida Therapeutics (PSTX), Greenwich LifeSciences (GLSI) and ACELYRIN, INC. (SLRN)

TipRanksMay 22 06:20 ET

Express News | HC Wainwright & Co. Maintains Buy on Acelyrin, Raises Price Target to $18

BenzingaMay 22 06:11 ET

Express News | HC Wainwright & Co. Reiterates Buy on Acelyrin, Maintains $16 Price Target

BenzingaMay 15 11:44 ET

Buy Rating Affirmed for ACELYRIN, INC. on Solid Financials and Promising Pipeline

TipRanksMay 15 06:22 ET

ACELYRIN, INC.: Strong Buy Recommendation on Promising Izo Drug Prospects and Strategic Advancements

TipRanksMay 14 20:25 ET

Acelyrin | 10-Q: Quarterly report

SEC announcementMay 14 16:27 ET · Announcements

Express News | ACELYRIN Inc : H.c. Wainwright Cuts Target Price to $18 From $28

ReutersMay 10 02:21 ET

ACELYRIN Is Maintained at Buy by HC Wainwright & Co.

ACELYRIN Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 9 14:05 ET

Express News | HC Wainwright & Co. Maintains Buy on Acelyrin, Lowers Price Target to $18

BenzingaMay 9 13:55 ET

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and ACELYRIN, INC. (SLRN)

TipRanksMay 9 12:30 ET

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), ACELYRIN, INC. (SLRN) and Moderna (MRNA)

TipRanksMay 9 12:20 ET

Express News | ACELYRIN Founder Shao-Lee Lin Steps Down As CEO; Mina Kim Appointed As CEO And To Board

BenzingaMay 9 08:32 ET

ACELYRIN Gil Labrucherie, Chief Fincl Officer, Additionally Named Chief Business Officer >SLRN

ACELYRIN Gil Labrucherie, Chief Fincl Officer, Additionally Named Chief Business Officer >SLRN

Dow JonesMay 9 08:04 ET

Express News | ACELYRIN Inc - Actively Considering Alternatives to Further Extend Its Cash Runway

ReutersMay 9 08:02 ET

Express News | ACELYRIN Inc - Cash Position Is Expected to Fund Operations Into 2026

ReutersMay 9 08:02 ET